VIVE News and Press, Viveve Medical Inc. From 01/21/21

New study design is more highly powered with improved patient selection criteria to better assess the primary efficacy endpoint Positive results could support a marketing application for new U.S. stress urinary incontinence indication ENGLEWOOD, CO / ACCESSWIRE / January 21, 2021...

Viveve Medical (VIVE) upsizes underwritten public offering of units for gross proceeds of approximately $27.6M.It is priced at a public offering price of $3.40 per Class A Unit.A.G.P./Alliance Global Partners acted as the sole book-running managePress Release For further details see: ...

ENGLEWOOD, CO / ACCESSWIRE / January 19, 2021 / Viveve Medical, Inc. ("Viveve") (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced the closing of an upsized underwritten public offering of units for gross proceeds of approximately $27.6 million, w...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning. on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks finished lower Friday, as optimism over President-elect Biden's proposed $1.9 trillion stimulus plan gave way to questions around bip...

Gainers: Datasea (DTSS) +90%.Lexicon Pharmaceuticals (LXRX) +85%.Pennsylvania Real Estate Investment Trust (PEI) +50%.DPW Holdings (DPW) +36%.Organogenesis (ORGO) +34%.Acacia Communications (ACIA) +33%.Bicycle Therapeutics (BCYC) +31%.AeroVironment (AVAV) +29%.Maxar Technologie...

Gainers: Organogenesis Holdings (ORGO) +33%. Lexicon Pharmaceuticals (LXRX) +30%. NantKwest (NK) +27%. Oragenics (OGEN) +25%. Bicycle Therapeutics (BCYC) +23%.Losers: Viveve Medical (VIVE) -23%. Cassava Sciences (SAVA) -12%. Timber Pharmaceuticals (TMBR) -11%. InflaRx N.V. (IFRX) -9...

Viveve Medical (VIVE) prices its upsized public offering of units for gross proceeds of ~$24M.Offering is comprised of 4,607,940 Class A common shares at $3.40/share, each unit consisting of one share of common stock and one warrant to purchase one share of common sto...

Volt Information Sciences VOLT -17% erasing yesterday's gains post Q4 results.Live Ventures LIVE -12% erasing yesterday's gains post FY results.Takung Art (TKAT) -11%.Nano Dimension NNDM -10% after prices $332.5M direct offering.Viveve Medical (VIVE) -1...

ENGLEWOOD, CO / ACCESSWIRE / January 14, 2021 / Viveve Medical, Inc. ("Viveve") (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced the pricing of an upsized underwritten public offering of units for gross proceeds of approximately $24 Million (or ...

InMode is an outperformer and leader in the growing medical aesthetic devices industry. Its products are made for a variety of purposes including liposuction, skin rejuvenation, cellulite treatment, and more. InMode is an asset-light business with high returns on capital and a flawles...